MSFT vs PATH: How Microsoft and UiPath Compare (2026)

Last updated August 2026

Short answer

MSFT is the larger of the two ($3.45T market cap): the incumbent the market prices for continued execution (19.96x forward earnings, beta 1.13). PATH is the smaller challenger ($6.61B), cheaper on forward earnings (14.08x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.

MSFT vs PATH: the tie-breaker metrics

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

MetricMSFTPATHWhat it tells you
Market cap$3.45T$6.61BSize. The larger name is the incumbent; the smaller has more room to grow and more to prove.
Forward P/E19.9614.08Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up.
Trailing P/E25.9021.27Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price.
Beta1.130.97Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through.
Price vs 52-week range56% of range33% of rangeWhere today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why.
Price / book7.803.49How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price.

Reading it: PATH is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

Before you buy: how MSFT and PATH affect your concentration

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. MSFT and PATH share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined MSFT and PATH exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

What does Microsoft (MSFT) do?

Microsoft (MSFT) is one of the largest and most diversified technology companies in the world, operating across three reporting segments. Productivity and Business Processes includes Microsoft 365 (Office, Teams, Dynamics 365) and LinkedIn. Intelligent Cloud covers Azure, GitHub, server products, and enterprise services. More Personal Computing spans Windows, gaming (Xbox plus the acquired Activision Blizzard), Surface devices, and search via Bing. Azure is the second-largest cloud computing platform in the world behind AWS, and Microsoft 365 is the dominant productivity suite for businesses globally. AI is woven across all of it through the Copilot product line and a deep partnership with OpenAI, in which Microsoft is both the primary cloud provider and a major investor. The company was founded in 1975 by Bill Gates and Paul Allen, is headquartered in Redmond, Washington, and is led by CEO Satya Nadella (since 2014). Microsoft is consistently the largest or one of the two largest publicly traded US companies by market cap, with enormous recurring cash flow and a multi-decade dividend-growth streak.

Full MSFT guide

What does UiPath (PATH) do?

UiPath builds and sells an integrated enterprise automation platform that combines traditional robotic process automation (RPA) with AI-powered capabilities including agentic automation, process orchestration, intelligent document processing, and governance tooling. Its core product, the UiPath Platform, enables AI agents, software robots, and human workers to collaborate in coordinated workflows across industries including financial services, healthcare, manufacturing, retail, and the public sector. The company makes money primarily through subscription and cloud software licenses, which generate high gross margins in the 83-85 percent range, supplemented by professional services revenue. ARR, the annualized value of active subscription contracts, is its primary business-health metric and stood at $1.853 billion as of January 31, 2026.

Full PATH guide

MSFT vs PATH: how do they differ?

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

  • MSFT drivers: AI as the platform; Closing the gap with AWS in cloud.
  • PATH drivers: Agentic Automation as the Next Growth Layer; Re-accelerating Revenue Growth with a Maturing Margin Profile.

Which fits which kind of investor

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The largest open question is the return on AI capex: Microsoft is spending more than $50 billion a year on AI and cloud infrastructure, and if enterprise adoption is slower than expected the payback stretches out. For PATH, the central bear case is platform displacement: generative AI and agentic tools embedded into Microsoft 365, ServiceNow, and cloud hyperscaler platforms could allow enterprises to automate complex workflows without a dedicated RPA layer, gradually eroding UiPath's core value proposition.

MSFT or PATH: which should you pick?

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick MSFT if you believe its drivers more; PATH if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the MSFT and PATH guides.

MSFT vs PATH: the full fundamentals

MSFT. For comparison, the S&P 500 trades at roughly 22x earnings on average. Microsoft's premium reflects its combination of growth, durability, margins, and AI exposure through Azure and OpenAI. It is not the highest P/E in mega-cap tech; NVIDIA, for example, trades at roughly 50x. The premium is justified as long as Azure keeps growing double digits and the AI capex earns a return; multiple compression risk rises if cloud growth slows. All figures are approximate as of early 2026 and refresh quarterly; verify against Microsoft's investor relations page or your broker.

PATH. UiPath's trailing P/E of roughly 17x sits well below the broader US software sector average of approximately 26x, reflecting the market's uncertainty about whether agentic AI tailwinds will translate into sustained double-digit ARR growth. The company's strong gross margin profile of 83 percent and $372 million in FY2026 free cash flow indicate a fundamentally healthy software business, but the stock has declined significantly from its post-IPO highs as growth decelerated and competition intensified. The forward P/E of roughly 12x implies the market is pricing in limited earnings growth, creating a potential valuation gap if the re-acceleration seen in recent quarters proves durable.

Headline figures (approximate, early 2026): MSFT shows revenue (fy2025 ending june) ~$245 billion, growing ~15% year over year, operating margin ~45%, among the highest of any company at Microsoft's scale, net income ~$95 billion, eps (ttm) ~$12.80; PATH shows revenue (fy2026, ended jan 31, 2026) ~$1.61 billion, revenue growth (fy2026 yoy) ~13%, arr (as of jan 31, 2026) ~$1.85 billion, gaap gross margin (fy2026) ~83%.

The bottom line: MSFT vs PATH

MSFT and PATH are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined MSFT and PATH exposure against your real portfolio. It is not an investment adviser.

Wondering how MSFT or PATH fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.

Investing in Microsoft with AI

Connect the broker you already use and ask Walnut's AI how MSFT fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.

FAQ

What is the difference between MSFT and PATH?

+

Microsoft (MSFT) is one of the largest and most diversified technology companies in the world, operating across three reporting segments. UiPath builds and sells an integrated enterprise automation platform that combines traditional robotic process automation (RPA) with AI-powered capabilities including agentic automation, process orchestration, intelligent document processing, and governance tooling. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.

Is MSFT or PATH the better stock?

+

Neither is universally better. MSFT is the larger incumbent; PATH is the smaller challenger and looks cheaper on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.

Which is cheaper, MSFT or PATH?

+

On forward P/E (as of August 2026), MSFT trades at 19.96x and PATH at 14.08x, so PATH is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.

Should you own both MSFT and PATH?

+

Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.

What are the risks of MSFT vs PATH?

+

MSFT: The largest open question is the return on AI capex: Microsoft is spending more than $50 billion a year on AI and cloud infrastructure, and if enterprise adoption is slower than expected the payback stretches out. Antitrust pressure is real, with the FTC and EU both active on Microsoft's stack over the years. The concentrated dependence on OpenAI as the AI partner of choice cuts both ways, since OpenAI is also, increasingly, a competitor. Cloud is competitive (AWS leads, Google Cloud and Oracle are investing heavily), and the valuation, while not the highest in mega-cap tech, embeds confidence in durable double-digit growth that could compress if Azure decelerates. PATH: The central bear case is platform displacement: generative AI and agentic tools embedded into Microsoft 365, ServiceNow, and cloud hyperscaler platforms could allow enterprises to automate complex workflows without a dedicated RPA layer, gradually eroding UiPath's core value proposition. Competition from Automation Anywhere, Blue Prism, and emerging agentic AI startups intensifies pricing pressure and increases customer acquisition costs. UiPath's revenue growth has been inconsistent historically, and approximately 24 percent of its outstanding shares are sold short, reflecting meaningful market skepticism about whether the agentic pivot will translate into durable ARR acceleration. Insider selling, including by founder Daniel Dines, has also weighed on investor sentiment.

Related comparisons

Browse all stock comparisons.

Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell MSFT or PATH; figures are approximate and dated (as of August 2026). Verify current data before investing.

    MSFT vs PATH: How Microsoft and UiPath Compare (2026), Walnut